Search Results
Haley N. Bavasi
Partner
Haley Bavasi is a partner in the Seattle office of Wilson Sonsini Goodrich & Rosati, where she focuses primarily on advising digital health companies across a range of privacy, transactional, research, and healthcare regulatory issues. In particular, Haley leverages her expertise in the Health Insurance Portability and Accountability Act (HIPAA), the U.S. federal health-privacy law, to provide early-stage companies with practical day-to-day counseling, as well advise as in the context of complex commercial transactions, M&A, and go-to-market strategy. Haley’s extensive experience with a wide range of cutting-edge digital health companies provides her with valuable market insights she leverages for her clients.
Andrea Linna
Partner
Andrea Linna is a partner at Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s digital health industry group and its healthcare practice. With more than a decade dedicated to healthcare law, Andrea exclusively represents digital health and healthcare IT clients, from emerging companies to established industry players, investors, and healthcare systems. Andrea guides her clients through the patchwork of federal and state laws that apply to digital health companies, addressing issues such as corporate practice of medicine, Stark Law compliance, Anti-Kickback Statute considerations, fee splitting, billing Medicare and Medicaid, contracting with commercial payors, value-based care arrangements, artificial intelligence, remote patient monitoring, online prescribing, scope of practice, and licensing requirements.
Eva F. Yin
Partner
Eva Yin, Ph.D., M.P.H., is a partner in Wilson Sonsini Goodrich & Rosati’s FDA regulatory, healthcare, and consumer products practice. Her practice includes conducting FDA and healthcare regulatory due diligence for corporate transactions; providing legal counsel to manufacturers regarding FDA approval/clearance for various products—including medical devices, mobile apps, and drugs, FDA compliance, regulation of promotional materials and labeling, and manufacturer compliance under federal and state healthcare laws, e.g., the federal Anti-Kickback Statute (AKS), False Claims Act (FCA), Sunshine Act, state licensing laws, corporate practice of medicine, etc.; reviewing contracts and compliance policies for manufacturers; and providing legal analysis and risk assessment of business models and fee arrangements involving patient assistance programs, healthcare professionals, or hospitals/clinics under federal and state healthcare laws and regulations.
Rob Parr
Partner
Rob Parr is a partner in the Boston office of Wilson Sonsini Goodrich & Rosati, where he leads the office’s information technology transactions practice. He represents companies in transactions focused on the exploitation of intellectual property rights and technology in a variety of industries. Rob represents many companies in the digital health industry in particular and plays a key role in the firm’s digital health initiative. He regularly drafts and negotiates a wide variety of complex commercial agreements, including services, distribution, strategic alliance and joint venture, supply, asset transfer, and intellectual property license agreements. Rob also represents clients with the intellectual property and commercial issues arising from financings, mergers, acquisitions, and initial public offerings. The International Association of Privacy Professionals has designated Rob as a Certified Information Privacy Professional (CIPP/US).
Megan J. Baier
Partner
Megan represents technology and life sciences clients in corporate transactional matters.
Mark B. Baudler
Partner
Mark is a corporate law veteran, having advised start-ups and mature public companies for more than 25 years.
Farah B. Gerdes
Partner
Farah focuses on the representation of pharmaceutical, biotechnology, medical device, and diagnostic companies in complex collaboration and partnering transactions.
Ali R. Alemozafar
Partner
Ali counsels clients on patent strategy, prosecution, and diligence for financings, M&A, and IPOs.
Kenji L. Funahashi
Partner
Ken represents technology-driven start-ups and large companies in corporate law and transactional matters.
Salil Gandhi
Partner
Salil Gandhi is a partner in the New York office of Wilson Sonsini Goodrich & Rosati and a co-leader of the firm’s emerging companies practice. Salil focuses on corporate and securities law and specializes in the representation of emerging growth companies throughout their lifecycles, particularly in the life sciences and technology sectors. He also counsels venture capital funds and other private equity funds on structuring and executing investment transactions ranging from angel to control investments, as well as portfolio dispositions.
Jake D. Gatof
Partner
Jake Gatof represents life sciences and technology companies, as well as their sponsors, through all stages of growth and investment. Jake joined the Boston office upon its founding, representing companies throughout their business life cycle, including with respect to venture capital financings, corporate governance, mergers and acquisitions, and other complex strategic transactions. He also represents leading growth equity, venture capital, and other institutional sponsors in connection with their investments, acquisitions, and other strategic transactions.
Daniel Glazer
Partner
Daniel counsels UK and European tech and life sciences companies on U.S. expansion and fundraising.
James T. Huie
Partner
James advises life sciences and tech companies on a wide variety of matters and has extensive experience working with venture capital firms and other investors in private equity and debt financings.
Jeana S. Kim
Partner
Jeana’s practice focuses on corporate and securities law matters for emerging growth companies, venture capital firms, and public companies.
Scott A. McKinney
Partner
Scott focuses on complex commercial and technology transactions and frequently advises companies with new and emerging technologies.
Melissa Rick
Partner
Melissa Rick is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where her practice focuses on corporate and securities transactions, with particular emphasis on the life sciences and technology industries. She advises emerging companies at all stages of maturity, including formation, initial funding, expansion, and exit. Melissa works with public and private companies on a range of transactions, including venture financings, initial public offerings, and mergers and acquisitions. She also counsels clients on matters such as general corporate law and governance and public company disclosure, as well as reporting with the U.S. Securities and Exchange Commission.
Yoichiro (Yokum) Taku
Partner
Yokum focuses on helping technology and growth companies at all stages of development.
Shawn Lichaa
Of Counsel
Shawn has almost a decade of in-house experience from a variety of healthcare and digital health settings, where he helped companies understand and operationalize healthcare regulatory requirements.
Nawa Lodin
Associate
Nawa Lodin is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she is member of the firm’s digital health industry group and its healthcare practice. Nawa represents clients in a full range of corporate transactions and compliance matters and provides guidance on a wide variety of state and federal laws and regulations including: the Health Insurance Portability and Accountability Act (HIPAA), Medicare and Medicaid fraud and abuse laws, the Stark Law, the Anti-kickback statute, corporate practice of medicine, use of artificial intelligence and machine learning, fee-splitting, and scope of licensure compliance.
Nawa has extensive experience on healthcare transactions, including mergers and acquisitions, venture and growth equity financings, and capital markets transactions, and has represented clients in acquisitions and financings involving a wide variety of healthcare providers, digital health, and life sciences companies. Nawa handles a range of healthcare matters including advising start-ups, drafting and negotiating clinical trial agreements, medical staff issues, telemedicine matters and providing healthcare compliance plans and training. Prior to joining the firm, Nawa was an associate at Simpson Thacher & Bartlett. Before that, she was an associate at Goodwin Procter.
Nawa has extensive experience on healthcare transactions, including mergers and acquisitions, venture and growth equity financings, and capital markets transactions, and has represented clients in acquisitions and financings involving a wide variety of healthcare providers, digital health, and life sciences companies. Nawa handles a range of healthcare matters including advising start-ups, drafting and negotiating clinical trial agreements, medical staff issues, telemedicine matters and providing healthcare compliance plans and training. Prior to joining the firm, Nawa was an associate at Simpson Thacher & Bartlett. Before that, she was an associate at Goodwin Procter.
Hale Melnick
Associate
Hale Melnick is an associate in the privacy and cybersecurity group of Wilson Sonsini Goodrich & Rosati. He primarily advises digital health companies across a range of privacy, transactional, research, and health care regulatory issues. In particular, Hale leverages his expertise in HIPAA, the CCPA, the GDPR, and other state, national, and international privacy laws and regulations to provide early-stage companies with practical day-to-day support in the area of health care.
Jonathan Trinh
Associate
Jonathan Trinh advises start-ups and emerging life sciences companies on FDA regulatory strategies involving drugs, medical devices, combination products, and AI/machine learning.
Mark W. Bellomy
Partner
Mark Bellomy is a partner in Wilson Sonsini Goodrich & Rosati’s Boston office, where he is a member of the technology transactions practice. Mark advises numerous domestic and international public and private biopharmaceutical, medtech, digital health, medical device, and life sciences companies on all of the transactions related to the discovery, development, supply, and commercialization of their products, technologies, and services. He counsels clients with respect to structuring and negotiating a wide range of arrangements designed to maximize the value of their businesses.
Steve E. Bochner
Partner
Steve has over 39 years of corporate law experience, serving as lead counsel for many of Silicon Valley's most prominent companies.
John M. Brust
Partner
John counsels start-ups in a wide range of matters, from formation and VC to IPOs and M&A.
James G. Clessuras
Partner
James assists clients with transactions driven by use or acquisition of technology and IP rights.
Robert G. Day
Partner
Bob represents companies and financial services entities, from innovative entrepreneurs to investment banks and venture capital and private equity firms.
Chris F. Fennell
Partner
Chris is a veteran attorney who advises tech and life sciences companies through all stages of development and growth.
Mark R. Fitzgerald
Partner
Mark is a veteran attorney who advises technology and life sciences companies on corporate law and transactional matters.
Bryan D. King
Partner
Bryan focuses on corporate and securities law matters for emerging growth companies, venture capital firms, and public companies.
Michael C. Labriola
Partner
Michael Labriola is a partner with Wilson Sonsini Goodrich & Rosati, where he counsels public and private technology, life sciences, and emerging growth companies through all stages of their growth. Michael has particular experience with Wilson Sonsini’s clients across the U.S. East Coast and Europe. He has a particular focus on supporting companies that undertake transformative events, such as growth financings, IPOs, acquisitions, and exit sales. Michael counsels clients in matters ranging from formation and early-stage venture financing to listings of publicly traded securities on U.S. and foreign exchanges to seasoned public offerings and private and public company acquisitions. He also has considerable experience in counseling publicly held companies on disclosure matters, SEC compliance, Nasdaq and NYSE listing matters, and other securities laws issues. In addition, Michael frequently represents investment banks, venture capital funds, and private equity firms in a broad range of investment transactions.
Scott K. Murano
Partner
Scott advises clients in a broad range of corporate transactions and related matters.
Philip H. Oettinger
Partner
Philip focuses primarily on the representation of medical device, biotechnology, pharmaceutical, diagnostic, and digital health companies in corporate governance, IPO, M&A, public company reporting, and private equity and debt financing matters.
Jeffrey D. Saper
Partner
Jeff specializes in public and private financings of technology and other emerging growth companies, as well as the representation of leading investment banks and corporate issuers in public offerings and M&A transactions.
Elton Satusky
Partner
Elton specializes in public and private corporate finance and corporate law and governance. He also has considerable M&A and venture capital experience.
Lowell Segal
Partner
Lowell represents pharmaceutical, biotechnology, medical device, and other technology-based companies in a wide range of strategic transactions and corporate matters.